酸浆果实抗阿尔茨海默病化学成分的研究

Research on the Chemical Constituents against Alzheimer's Disease of the Fruits of Physalis alkekengi L. var. franchetii (Mast.) Makino.

作者信息

Teng Yang, Yuan Qi, Wu You, Wu Shuang, Su Jin, Zhang Pengxia, Zhang Yu

机构信息

College of Pharmacy, Jiamusi University, Jiamusi, 154007, China.

Heilongjiang Pharmaceutical Research Institute, Jiamusi, 154007, China.

出版信息

Chem Biodivers. 2023 Sep;20(9):e202301075. doi: 10.1002/cbdv.202301075. Epub 2023 Aug 10.

Abstract

Physalis alkekengi L. var. franchetii (Mast.) Makino (PA) is a natural plant which is utilised as a traditional herbal medicine. It has properties that make it effective against inflammation and free radical damage. In the present study, the major constituents of four extraction parts of the fruits of PA (PAF) were investigated by combining ultra-performance liquid chromatography with quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS). The mice model of Alzheimer's disease (AD) induced by aluminum chloride (AlCl ) combined with D-galactose (D-gal) was established to comprehend the mechanism behind PAF's anti-AD activity from both behavioural and pathological perspectives. The results showed that four extraction parts of PAF (PAFE) had favorable anti-AD effects and the ethyl acetate (EA) group showed the best activity. UPLC-Q-TOF-MS analysis identified Physalin B, Nobiletin and Caffeic acid as the main anti-AD active constituents in EA extract. This study reveals that PAF can reduce neuroinflammatory damage by inhibiting p38 mitogen-activated protein kinase (p38 MAPK) signaling pathway, which is the theoretical basis for clinical development and utilization of PAF in AD therapy.

摘要

酸浆(Physalis alkekengi L. var. franchetii (Mast.) Makino,PA)是一种天然植物,被用作传统草药。它具有抗炎和抗自由基损伤的特性。在本研究中,采用超高效液相色谱-四极杆飞行时间质谱联用技术(UPLC-Q-TOF-MS)对酸浆果实四个提取部位(PAF)的主要成分进行了研究。建立了氯化铝(AlCl)联合D-半乳糖(D-gal)诱导的阿尔茨海默病(AD)小鼠模型,从行为学和病理学角度探讨PAF抗AD活性的作用机制。结果表明,PAF的四个提取部位(PAFE)均具有良好的抗AD作用,其中乙酸乙酯(EA)组活性最佳。UPLC-Q-TOF-MS分析确定酸浆苦素B、川陈皮素和咖啡酸为EA提取物中的主要抗AD活性成分。本研究表明,PAF可通过抑制p38丝裂原活化蛋白激酶(p38 MAPK)信号通路减轻神经炎症损伤,这为PAF在AD治疗中的临床开发和应用提供了理论依据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索